Studio Investment Management LLC Bristol Myers Squibb CO Transaction History
Studio Investment Management LLC
- $455 Million
- Q4 2024
A detailed history of Studio Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Studio Investment Management LLC holds 500 shares of BMY stock, worth $24,090. This represents 0.01% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$24,090
Previous $25,000
12.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,802Shares Held
1.61BCall Options Held
27MPut Options Held
27.3M-
Vanguard Group Inc Valley Forge, PA191MShares$9.22 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.21 Billion0.52% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.58 Billion0.22% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...